Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Combination Therapy for Non-Hodgkin's Lymphoma
Recruiting1 awardPhase 1 & 2
Fairway, Kansas
This trial will research the effectiveness of a combination of 3 medicines (maplirpacept, glofitamab, obinutuzumab) for non-Hodgkin lymphoma, which is a cancer of the lymphatic system. Different doses of maplirpacept will be studied.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service